Pharmadrug Dives Into Psychedelics, Buys Super Smart
Terms of the deal were not disclosed.
Toronto-based Pharmadrug announced Wednesday it has entered into a non-binding letter of intent with Interrobang Ltd., which does business as Super Smart, to buy 100% of the company's issued and outstanding common shares.
The goal its to grow Pharmadrug's existing business — which is focused on cannabis distribution — into the burgeoning psychedelics, or "magic mushrooms," space.
The LOI will be replaced by a final agreement between Pharmadrug and Super Smart and will be subject to shareholder and regulatory approvals.
Super Smart is under the helm of CEO Harry Resin, a former writer for High Times. Joshua Kasakevich is the company's COO, focusing on corporate strategy, branding, advertising and retail sales.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.